Catalyst Pharmaceutical Partners Aktie
21,02
EUR
-0,80
EUR
-3,67
%
23,05
USD
-1,07
USD
-4,44
%
Werbung
Catalyst Pharmaceutical Partners Aktie Analyse
21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |
Werbung
Werbung